There is still no consensus on the optimal management of COVID-19 within the general population due to the emerging evidence base. High-risk groups, including kidney transplant recipients living with HIV present unique additional challenges. Here we discuss two kidney transplant recipients living with HIV with SARS-CoV-2 infection and their clinical course, and review the existing literature for this subset of challenging patients.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, HIV, Renal transplant, transplantation, calcineurin inhibitor,
【저자키워드】 COVID-19, SARS-CoV-2, HIV, Renal transplant, transplantation, calcineurin inhibitor,